Evaluation of the Safety and Efficacy of REBORN System for Lipolysis Treatment

LIPOLYSIS Clinical Trial

Official title:
EVALUATION OF THE SAFETY AND EFFICACY OF REBORN LED SYSTEM FOR NON-INVASIVE LIPOLYSIS TREATMENT

Status Completed

Clinical Trial Summary

The Lightfective ReBorn System is intended for non-invasive lipolysis of the flanks in individuals with a Body Mass Index (BMI) of 30 or less. The device is intended to affect the appearance of visible fat bulges in the flanks.

Clinical Trial Description

Body countering and fat reduction treatment are considered to be one of the most popular aesthetic procedures. The Lightfective' ReBorn LED System provides non-invasive fat reduction treatment. The primary efficacy objective is to demonstrate fat reduction in the treated area after treatment with the ReBorn LED system. study population, Healthy subjects who seek for fat reduction treatments in the flanks area. Each subject will undergo 2 treatment visits (one month apart) and follow-up visits. ;

Study Design

Related Conditions & MeSH terms

LIPOLYSIS

Clinical Trial Details

NCT number	NCT05507528
Study type	Interventional
Source	Lightfective Ltd
Contact
Status	Completed
Phase	N/A
Start date	June 30, 2022
Completion date	November 11, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03675464` - Study of Human Adipose Tissue (LOSHAT)
Terminated	`NCT03171051` - LED Device for Non-Invasive Lipolysis	N/A
Completed	`NCT03721185` - Efficacy of a Lipolytic Cream in an Overweight and Obesity Treatment	N/A
Completed	`NCT03588702` - RF and PEMF Following Liposuction	N/A
Completed	`NCT01177787` - Clinical Efficacy of Cryolipolysis on the Fat of Thigh in Korean Women	N/A
Completed	`NCT03062163` - Efficacy and Safety of Resveratrol and Lipoic Acid Transdermal Patch for Lipolysis in Overweight Volunteers	N/A
Terminated	`NCT04881175` - Histological Study on Safety and Efficacy of a RF Device Flexible Applicator for Non-Invasive Lipolysis	N/A